MedTrace Logo

Clinical and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics

NCT04711551 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-02-17

No results posted yet for this study

Summary

the aim is to improve the evaluation of the outcomes of regenerative medicine treatments performed in the regenerative medicine centers involved in the study.

patients who undergo regenerative medicine treatments present acute and chronic pathologies of the musculoskeletal system, of the stomatological system and of the integuments.

Objective pre, peri and post treatment evaluations are collected. A dedicated software collects the PROMs compiled by the patients, the objective clinical data and the biomolecular evaluations.

Conditions

  • Musculoskeletal System Disease

Interventions

COMBINATION_PRODUCT

PRP and related devices to abtain platelet concentrate from whole blood, medullary and adipose tissue and related devices

PRP and related devices to abtain platelet concentrate from whole blood, medullary and adipose tissue and related devices

Sponsors & Collaborators

  • I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

    lead OTHER

Principal Investigators

  • Laura De Girolamo · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-30
Primary Completion
2030-05-30
Completion
2030-05-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04711551 on ClinicalTrials.gov